Déjà vu experiences in schizophrenia: relations with psychopathology and antipsychotic medication.
نویسندگان
چکیده
To clarify why patients with schizophrenia show déjà vu experiences less frequently, we studied déjà vu experiences in 113 schizophrenic patients in relation to psychopathologies and antipsychotic medication. Déjà vu experiences were observed in 53.1% of the schizophrenic patients. Patients with increased negative symptoms (blunted affect, motor retardation, emotional withdrawal, conceptual disorganization, and mannerisms) had déjà vu experiences less frequently. The other psychopathologies were not significantly associated with presence of déjà vu experiences. The dosage of antipsychotic drugs was significantly correlated with the frequency of déjà vu experiences. This correlation was not affected by their psychopathologies at the time of examination. The decreased frequency of déjà vu experiences in patients with schizophrenia may be mainly due to the negative symptoms. The positive relation between frequency of déjà vu experiences and the dosage of neuroleptics remains uncertain.
منابع مشابه
Déjà vu experiences in patients with schizophrenia.
To investigate whether déjà vu experiences are psychopathologic phenomena, we studied the frequency and characteristics of déjà vu experiences in patients with schizophrenia. One hundred thirteen patients with schizophrenia and 386 nonclinical control subjects were evaluated with the Inventory of Déjà vu Experiences Assessment. The frequency and features of déjà vu experiences were compared bet...
متن کاملAn Overview Perspective on what Déjà Vu is (Part 1)
Submit Manuscript | http://medcraveonline.com J Psychol Clin Psychiatry 2015, 2(6): 00036 experiences; Déjà subtypes; Déjà terminology; Déjà vu; déjà vu books; History; Memory; Modern era; Multidimensional scaling; Neppe; Phenomenology; psi; Psychodynamic; Psychotic Déjà Vu; Redintegration; Restricted paramnesia; Schizophrenic Déjà Vu; SPE Déjà Vu; Subjective psi experience Déjà Vu; Temporal Lo...
متن کاملبررسی اثر افزودن نالترکسان به داروهای آنتی سایکوتیک، بر علایم مثبت و منفی بیماران مبتلا به اسکیزوفرنیای مزمن
Background and Purpose: In recent years, review of opioid system and its changes in the psychopathology of schizophrenia through thear probable role our on neuronal synopses and cell body of dopaminergic neurons and also decrease dopamine secretion from acumbans nuclei and effects of opium agonists in treatment of those patients has been adventajes for clinicians. Materials and methods: I...
متن کاملEvaluation of the efficacy and safety of pregabalin as an adjuvant to antipsychotics in patients with chronic schizophrenia: a six-week pilot double-blind placebo-controlled trial
Introduction and objectives: Antipsychotics or dopamine receptor antagonists are the major components of treatment but about 10-20% of patients with schizophrenia do not benefit from treatment with antidopaminergic agents, indicating other neuronal systems may be involved in this disorder (2). Dysregulation of both excitatory and inhibitory mechanisms N-Methyl-D-aspartic acid (NMDA) and γ-Amino...
متن کاملAttitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia.
OBJECTIVE Attitude toward antipsychotic medication is considered as one of the main predictors for medication adherence in schizophrenia. The present non-interventional cross-sectional study aims to explore the associations between attitudes toward antipsychotic medication, insight and other clinical variables in outpatients with schizophrenia. METHOD Attitudes toward antipsychotic medication...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Comprehensive psychiatry
دوره 48 6 شماره
صفحات -
تاریخ انتشار 2007